Prior to this appointment, Mr. Hess served as InVivo’s director of product development, a position he has held since February. Before joining InVivo, he spent eight years at Stryker developing biomaterial technologies for the orthopedic market. At Stryker, he was instrumental in leading multiple product development teams through the FDA process and developing HydroSet.
More Articles on Orthopedic Devices:
US Soft Tissue Solutions to Grow to $2B
Study: MoM Hip Implants Not Linked to Cancer After 7 Years
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.